RN

Rajendra Namdeo Patil

Active Director Director DIN 00077309
DIN 00077309 First appointment Jul 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jul 2002
Shareholding value •••• Premium profile

About Rajendra Namdeo Patil

Data last updated:

Rajendra Namdeo Patil is a Director at Ganpati Diagnostic And Research Centre Private Limited (since 2019) and Director at Chaitanya Healthcare Private Limited (since 2007). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹7.09 Cr; the largest is Ganpati Diagnostic And Research Centre Private Limited at ₹4.40 Cr (FY 2026). Earlier, Rajendra Namdeo Patil was a Director at Niramay Neonatal And Pediatric Intensive Care Unit Private Limited (2005–2021) and Director at Surya Intensive Care Private Limited (2002–2011).

DIN 00077309
Primary Designation Director
Industry Healthcare
First Appointment 04 Jul 2002
Oldest Company Age 28 yrs
Largest company Ganpati Diagnostic And Research Centre Private Limited · ₹4.40 Cr (FY 2026)
Combined revenue ₹7.09 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Feb 20191998₹4.40 Cr (FY 2026)Active
Chaitanya Healthcare Private Limited U85110MH2007PTC169578
Director03 Apr 20072007₹2.69 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Dec 20052005₹2.45 Cr (FY 2024)Active
Surya Intensive Care Private Limited U85110MH2001PTC131788
Director04 Jul 20022001Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ganpati Diagnostic And Research Centre Private Limited
Chaitanya Healthcare Private Limited
Niramay Neonatal And Pediatric Intensive Care Unit Private Limited
Surya Intensive Care Private Limited
Premium access

Shareholding and investment profile for Rajendra Namdeo Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Namdeo Patil

Rajendra Namdeo Patil currently holds 2 directorships: Ganpati Diagnostic And Research Centre Private Limited (Director, since 22 Feb 2019, revenue ₹4.40 Cr (FY 2026)); Chaitanya Healthcare Private Limited (Director, since 03 Apr 2007, revenue ₹2.69 Cr (FY 2025)).

Rajendra Namdeo Patil was first appointed on 04 Jul 2002 as Director at Surya Intensive Care Private Limited. The most recent appointment on record is 22 Feb 2019 at Ganpati Diagnostic And Research Centre Private Limited.

The 2 current companies of Rajendra Namdeo Patil that report revenue have a combined latest revenue of ₹7.09 Cr: Ganpati Diagnostic And Research Centre Private Limited ₹4.40 Cr (FY 2026); Chaitanya Healthcare Private Limited ₹2.69 Cr (FY 2025).

Rajendra Namdeo Patil held 2 earlier board appointments: Niramay Neonatal And Pediatric Intensive Care Unit Private Limited (Director, 23 Dec 2005 to 03 May 2021); Surya Intensive Care Private Limited (Director, 04 Jul 2002 to 25 Nov 2011).

The current boards of Rajendra Namdeo Patil's companies include Anil Jagannath Khadke (Ganpati Diagnostic And Research Centre Private Limited), Girish Ichharam Gajare (Ganpati Diagnostic And Research Centre Private Limited), Sanjeev Nilkantha Zambare (Ganpati Diagnostic And Research Centre Private Limited), Shrikant Pitambar Rane (Ganpati Diagnostic And Research Centre Private Limited), Sunil Vasudeo Chaudhari (Ganpati Diagnostic And Research Centre Private Limited), Arati Rajendra Patil (Chaitanya Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available